Top Banner
Addressing gaps in clinically useful evidence on drug- drug interactions Update to W3C HCLS September 10 th 2013 Richard Boyce, University of Pittsburgh Department of Biomedical Informatics
11

Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

May 07, 2015

Download

Sports

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

Addressing gaps in clinically useful evidence on drug-drug interactions

Update to W3C HCLSSeptember 10th 2013

Richard Boyce, University of Pittsburgh

Department of Biomedical Informatics

Page 2: Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

A new paradigm for drug-drug interaction knowledge representation

Product labeling

Scientific literature

A framework for representing PDDI assertions and evidence as interoperable Linked Data available for community annotation

Pharmacoepidemiology studies

Semantic annotation

High priority PDDIs for research

Semantic annotation

Reduced risk of a PDDI medication

error!

Clinical experience

Better synthesis of PDDI evidence, easier identification of gaps

Expected benefits:• More complete and accurate PDDI evidence• Better informed pharmacists and other

clinicians• More effective PDDI alerting and decisions

support systems

Page 3: Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

DailyMed Linked Structured Product Labels

• LinkedSPLs is a Linked Data version of SPLs– http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/

• >40,000 FDA-approved prescription and over-the-counter drugs present in DailyMed (09/2013)

• simplifies access to SPL content• interoperable with other important drug

terminologies and resources– RxNorm, NDF-RT, DrugBank, ChEBI

• Pharmacogenomics biomarker statements– http://www.youtube.com/watch?v=Te546vOiruo

Page 4: Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

PDDI information mashups

http://dbmi-icode-01.dbmi.pitt.edu/dikb-evidence/outfiles-poc-10252012/dikb-label-mashup-citalopram-001714c1-a292-40be-bfbd-0ff67193ace6.html

Page 5: Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

Open Data Annotation

http://www.openannotation.org/spec/core/

Page 6: Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

Semantic Annotation of potential drug-drug interactions (PDDIs)

Page 7: Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

Scientific Discourse modeling

Page 8: Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

Drug Interaction Knowledge Base (DIKB) Open Data Anotation + Scientific Discourse

• See • >300 evidence sources • >1500 links to ~1300

assertions

A production rule base for inferring pharmacokinetic PDDIs

DIKB: http://dbmi-icode-01.dbmi.pitt.edu/dikb/

Initial conversion (not ready for release):http://swat-4-med-safety.googlecode.com/svn/trunk/analyses/dikb-open-annotation/

Page 9: Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

Work in progress…A pipeline for the extraction PDDIs from SPLs and publishing them as semantically annotated Linked Data

Page 10: Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

Potential for PDDI semantic annotation dissemination

• As Linked Data, it automatically extends– DrugBank, ChEBI, RxNorm, NDF-RT

• A user friendly knowledge base portal– Currently testing Domeo: http://swan.mindinformatics.org/

– Enables community annotation and scientific discourse

• Other possibilities:– The FDAs SPL indexing initiative

• Could guide future requirements for SPL submissions• Complements our work on representing pharmacogenomics clinical

statements [18]

Page 11: Brief update to W3C HCLS on representing and linking potential drug-drug interaction knowledge

AcknowledgementsCollaborators: • Harry Hochheiser, Qian Zhu, Robert Freimuth, Carol

Collins, John Horn, Mathias Brochhausen, Serkan Ayvaz, Majid Rastegar-Mojarad, Anita DeWaard, Jodi Schneider, Maria Liakata, Oktie Hassanzadeh, Joanne Luciano, Michel Dumontier, and the W3C HCLS

Funding:• Agency for Healthcare Research and Quality

(K12HS019461). • NIH/NCATS (KL2TR000146),• NIH/NIGMS (U19 GM61388; the Pharmacogenomic

Research Network) • NIH/NLM (T15 LM007059-24)